Bicara Therapeutics

Bicara Therapeutics is a clinical-stage company developing first-class biologics that combine the precision of targeted therapy with the power of immunotherapy. The company's dual-action biologics are designed to deliver immunomodulatory payloads directly to the tumor microenvironment, enhancing immune cell activity and potentially providing lasting efficacy. We develop first-class bifunctional antibodies that integrate the precision of targeted therapy with the strength of immunotherapy. Our approach enables us to precisely activate a potent immune response at the tumor site, minimizing the likelihood of systemic side effects.